Stay updated on SENSITIZE: 4SC-202 + Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the SENSITIZE: 4SC-202 + Pembrolizumab Clinical Trial page.

Latest updates to the SENSITIZE: 4SC-202 + Pembrolizumab Clinical Trial page
- Check3 days agoChange DetectedRevision upgraded from v3.6.0 to v3.6.2, indicating a newer build of the page. No study-related content or functionality appears to be altered by this update.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page now includes a recruitment status notice indicating no further participant recruitment, and adds helpful guidance links such as How to Read a Study Record, Common Questions, and How to Join a Study. Additionally, the Intervention/Treatment label formatting is adjusted and the site revision tag updated from v3.5.5 to v3.6.0.SummaryDifference0.5%

- Check24 days agoChange DetectedThe page revision tag was updated from v3.5.4 to v3.5.5, signaling a minor page build update. No study content or user-facing details are affected by this change.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, indicating an update to the study record. This change reflects version control activity rather than a substantive modification to the study information.SummaryDifference0.1%

- Check67 days agoChange DetectedThe page revision/version label has been updated from v3.5.0 to v3.5.3, indicating a minor site release rather than a change to the clinical trial record.SummaryDifference0.1%

- Check95 days agoChange DetectedNapoli, Italy was updated to Naples, Italy in the locations list.SummaryDifference0.1%

Stay in the know with updates to SENSITIZE: 4SC-202 + Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SENSITIZE: 4SC-202 + Pembrolizumab Clinical Trial page.